Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedA new Completed status with Study Status and Recruitment Status entries was added, along with corresponding dates, and the prior Active, not recruiting status was removed. This documents that the trial has concluded and is no longer recruiting.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page’s displayed software/site revision was updated from v3.5.0 to v3.5.3, reflecting a minor ClinicalTrials.gov release rather than any change to the underlying study record.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedAdded a new Study Status entry to the record history in the latest revision (v3.5.0). The older Revision: v3.4.3 was removed (2025-08-29).SummaryDifference0.2%

- Check61 days agoChange DetectedAdded a new history entry: Revision: v3.4.3, and removed Revision: v3.4.2.SummaryDifference0.0%

- Check82 days agoChange DetectedA new revision entry v3.4.2 appears in the history, and the previous revision v3.4.1 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check90 days agoChange DetectedHistory shows a minor revision update from v3.4.0 to v3.4.1 with no accompanying changes to study content or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.